Live feed
·
INSIDERFilingvia Quantisnow
OnKure Therapeutics Inc. logo

Director Mathers Edward T was granted 4,694 shares, increasing direct ownership by 182% to 7,274 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow market dataNASDAQ
OnKure Therapeutics Inc. logo
OKUR
OnKure Therapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2021
Follow OKURFull OKUR profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OKUR (OnKure Therapeutics Inc.) and more on Quantisnow.